- Monday
- April 19th, 2021
Ontario and Alberta will start offering the AstraZeneca-Oxford COVID-19 vaccine to people age 40 and over starting Tuesday.A spokesperson for Ontario Health Minister Christine Elliott said the shot will be offered at pharmacies and primary care settings. In a statement Sunday, Alexandra...
Ontario will start offering the AstraZeneca-Oxford COVID-19 vaccine to people age 40 and over starting Tuesday.A spokesperson for Health Minister Christine Elliott said the shot will be offered at pharmacies and primary care settings. In a statement Sunday, Alexandra Hilkene said the province...
Ontario will start offering the AstraZeneca-Oxford COVID-19 vaccine to people 40 years of age and over starting Tuesday. A spokesperson for Health Minister Christine Elliott said the shot will be offered at pharmacies and primary care settings. In a statement Sunday, Alexandra Hilkene said...
One consequence of the coronavirus pandemic has been global restrictions on mobility. This, in turn, has had an effect on pollution levels in the atmosphere. Researchers from across the world are using this unique opportunity to take measurements, collect data,...
The list of known genetic mitochondrial disorders is ever-growing, and ongoing research continues to identify new disorders in this category. In an article recently published in Brain, a Japanese-European team of scientists, including researchers from Fujita Health University, describe mutations...
Being constantly hungry, no matter how much you eat -- that's the daily struggle of people with genetic defects in the brain's appetite controls, and it often ends in severe obesity. In a study published in Science on April 15,...
Researchers from Kumamoto University (Japan) have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced kidney function, glomerular...
WASHINGTON -- A decision on whether to end a U.S. pause in vaccinations with the Johnson & Johnson COVID-19 shot is likely by Friday, top U.S. pandemic advisor Anthony Fauci said Sunday. A government-convened expert panel has been assessing the...
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma. When the study was launched, it...

All posts loaded
No more posts